Counterfeit

Identity & Access Forum Spring Market Snapshot: Mobile Driver’s Licenses, Biometrics and Access Management Innovation

Retrieved on: 
Tuesday, April 9, 2024
Mastercard, Facial recognition, Counterfeit, Organization, Government, Ecosystem, Growth, Apple, DHS, Education, Patient, Travel, Research, Forum, DSCSA, Identity, NIST, Woman, Statistics, Generation Z, Fraud, String interpolation, RIV, Interest, Access, ID, IDS, Arizona Department, TSA, Gen, Android, Map, Online shopping

The future of identity and authentication is digital and mobile driver’s licenses are the next step in identity credentialing.

Key Points: 
  • The future of identity and authentication is digital and mobile driver’s licenses are the next step in identity credentialing.
  • Eric Jorgensen, director of the Arizona Department of Transportation’s Motor Vehicle Division, shared this sentiment while delivering the Identity and Access Forum Meeting’s keynote address.
  • The Identity and Access Forum’s primary focus is to provide a platform for solving cross-industry challenges and promoting innovation.
  • By joining the Secure Technology Alliance, members will have access to activities within the U.S. Payments Forum and the Identity and Access Forum and additional Alliance working committees.

Pharma Source Direct, Inc. Earns NABP Drug Distributor Accreditation

Retrieved on: 
Monday, March 18, 2024
Pharmacist, Counterfeit, Doctor of Pharmacy, Pharmacy, Public, Accreditation, Active ingredient, Ground substance, NABP, API, Safety, National Association

ENGLEWOOD, Colo., March 18, 2024 /PRNewswire-PRWeb/ -- Pharma Source Direct, Inc. has earned Drug Distributor Accreditation from the National Association of Boards of Pharmacy® (NABP®).

Key Points: 
  • ENGLEWOOD, Colo., March 18, 2024 /PRNewswire-PRWeb/ -- Pharma Source Direct, Inc. has earned Drug Distributor Accreditation from the National Association of Boards of Pharmacy® (NABP®).
  • "We are thrilled to announce that Pharma Source Direct, Inc. has achieved NABP Drug Distributor Accreditation," said Pharma Source President Matthew Johnson.
  • "We are thrilled to announce that Pharma Source Direct, Inc. has achieved NABP Drug Distributor Accreditation," said Matthew Johnson, President of Pharma Source Direct, Inc. "This prestigious recognition underscores our unwavering commitment to quality, safety, and compliance in the pharmacy compounding industry.
  • "NABP congratulates Pharma Source Direct, Inc. on achieving this important recognition," says NABP Executive Director/Secretary Lemrey "Al" Carter, PharmD, MS, RPh.

Global Blockchain Technology In Healthcare Market Analysis 2024-2034, Featuring Profiles for Solve.Care, iSolve, IBM, Guardtime, Medicalchain, Oracle, Blockpharma, Change Healthcare and BurstIQ

Retrieved on: 
Friday, March 15, 2024
Counterfeit, Prevalence, Health, Internet of things, Blockchain, GDPR, Hospital, Research, Roger Hawkins (drummer), General Data Protection Regulation, Investment, Clinical trial, USD, Data management, Electronic health record, Cryptocurrency

DUBLIN, March 15, 2024 /PRNewswire/ -- The "Global Blockchain Technology In Healthcare Market Analysis & Forecast to 2024-2034: Market By Network Type; By Application; By End-user; and By Region" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 15, 2024 /PRNewswire/ -- The "Global Blockchain Technology In Healthcare Market Analysis & Forecast to 2024-2034: Market By Network Type; By Application; By End-user; and By Region" report has been added to ResearchAndMarkets.com's offering.
  • Increased collaborations to introduce innovative blockchain solutions in the healthcare sector is predicted to boost the market growth during the forecast period.
  • In the healthcare sector, a blockchain network is employed to gather and retrieve patient information from hospitals, diagnostic labs, pharmaceutical firms, and doctors.
  • Presently, Ethereum, a widely adopted technology in healthcare, functions as a prominent example of a "permission-less" blockchain system within the public network domain.

908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook

Retrieved on: 
Tuesday, March 5, 2024
Hardware, Chemicals, Plastics, Health Technology, Manufacturing, Consumer Electronics, Other Health, Technology, Pharmaceutical, General Health, Medical Devices, Other Manufacturing, Biotechnology, Science, Other Science, Research, Health, MASS, Process analytical technology, PAT, Growth, Expansion, Counterfeit, Webcast, Video game

The installed base grew to 2,853 devices with 139 devices placed during the fourth quarter 2023.

Key Points: 
  • The installed base grew to 2,853 devices with 139 devices placed during the fourth quarter 2023.
  • Gross profit was $7.3 million for the fourth quarter of 2023, compared to $5.9 million for the corresponding prior year period.
  • Operating expenses were $17.0 million for the fourth quarter of 2023, compared to $16.3 million for the corresponding prior year period.
  • 908 Devices will host a conference call to discuss the fourth quarter and full year 2023 financial results before market open on Tuesday, March 5, 2024 at 5:30 am Pacific Time / 8:30 am Eastern Time.

Veteran’s Health Administration Joins Pulse by NABP

Retrieved on: 
Tuesday, January 23, 2024
Patient, Counterfeit, Health, Doctor of Pharmacy, Pharmacist, Veteran, National Association, Safety, VHA, DSCSA, NABP, Veterans' affairs, Medical device

To that end, VHA will require all current and future vendors (trading partners) that provide prescription products within the Veterans Affairs (VA) health system to register with Pulse by NABP.

Key Points: 
  • To that end, VHA will require all current and future vendors (trading partners) that provide prescription products within the Veterans Affairs (VA) health system to register with Pulse by NABP.
  • As a public service, NABP is providing free registration on the Pulse platform for any member of the prescription drug supply chain.
  • We are grateful that NABP is providing free registration for all members of the supply chain.”
    “We are pleased to welcome VHA to Pulse,” said Lemrey “Al” Carter, PharmD, MS, RPh, executive director/secretary of NABP.
  • “VHA’s participation in Pulse will help to strengthen the security of the pharmaceutical supply chain and protect our nation’s veterans from counterfeit drugs.”

Pharmaceutical Traceability Market size to grow by USD 17.92 billion from 2023-2028

Retrieved on: 
Thursday, January 11, 2024
Hospital, Medication, Pharmacy, Government, ROW, Counterfeit, GPS, Data management, Pharmacovigilance, Biometrics, FREE, EPC, Blockchain, App Store (iOS/iPadOS), Safety, Drug development, USD, GTIN, Organization, Electronic health record, RFID, Research, EHR, Growth, Medical device

NEW YORK, Jan. 10, 2024 /PRNewswire/ -- The pharmaceutical traceability market size is expected to grow by USD 17.92 billion from 2023 to 2028.

Key Points: 
  • NEW YORK, Jan. 10, 2024 /PRNewswire/ -- The pharmaceutical traceability market size is expected to grow by USD 17.92 billion from 2023 to 2028.
  • The global pharmaceutical filtration market size is estimated to grow by USD 10,219.87 million at a CAGR of 10.47% between 2022 and 2027.
  • The global pharmaceutical equipment market size is estimated to grow by USD 5,454.44 million at a CAGR of 6.67% between 2022 and 2027.
  • Growth of the pharmaceutical traceability market across North America, Europe, Asia, and ROW
    Comprehensive analysis of factors that will challenge the growth of pharmaceutical traceability market vendors.

Partnership for Safe Medicines Condemns the Weakening of the U.S. Drug Supply through Canadian Drug Importation

Retrieved on: 
Friday, January 5, 2024
Public Policy, Government, Pharmaceutical, White House, Federal Government, General Health, Health, FDA, Other Policy Issues, Healthcare Reform, Counterfeit, Pharmacy, PSM, Partnership, Patient, Food, Safdar, Risk, HIV

Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the U.S. Food and Drug Administration’s final decision to approve Florida’s Canadian drug importation plan.

Key Points: 
  • Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the U.S. Food and Drug Administration’s final decision to approve Florida’s Canadian drug importation plan.
  • “The United States government’s decision to approve Florida’s Canadian drug importation plan weakens our nation’s safe drug supply, putting American patients at risk.
  • This decision breaks our closed loop system and opens the door to counterfeiters and others who will be more than happy to meet demand.
  • For more information and to find resources about counterfeit drugs and more, visit safemedicines.org or contact [email protected] .

Content Protection Market to grow by USD 1.03 billion from 2023 to 2028 | Market is fragmented due to the presence of prominent companies like Adobe Inc., Alphabet Inc. and Cisco Systems Inc., and many more - Technavio

Retrieved on: 
Wednesday, December 20, 2023
Intellectual property, DRM, RMI, Protection, Digital rights management, USD, Geography, Cloud computing, Phishing, Computer security, Market, Content delivery network, CDN, Digital asset, IP, Google Chrome, Reproduction, Assets under management, Copyright, Digital watermarking, Blockchain, Ecosystem, Digital, Kudelski Group, Digital signature, Cisco, Digital forensics, Counterfeit, Content, Alphabet Inc., Culture, Signature, Adobe Media Server, Combat, Adobe Inc., Digital recording, MAM, Intelligence, Intel, Growth, Microsoft, Security printing

The content protection market is fragmented owing to the presence of many global and regional companies.

Key Points: 
  • The content protection market is fragmented owing to the presence of many global and regional companies.
  • Cisco Systems Inc. - The company offers content protection solutions such as Cisco Email Security Appliances and Cisco Web Security Appliances.
  • Blockchain for Content Protection offers immutable and transparent records, elevating content protection by enabling secure and traceable transactions while combating tampering and unauthorized alterations.
  • Content Delivery Network (CDN) Security Market size is estimated to grow at a CAGR of 30.72% between 2022 and 2027.

Global Pharmaceutical Traceability Research Report 2023: Market Size, Share, Trends, Opportunities, and Forecast, 2018-2023 and 2023-2028 - ResearchAndMarkets.com

Retrieved on: 
Friday, December 15, 2023
Health, Pharmaceutical, Internet of things, Patient safety, EMA, Blockchain, FDA, Mobile app, Humidity, RFID, Counterfeit, Temperature, Counterfeit medications, Public, Transport, Generic drug, Fine chemical, Medical device, Pharmaceutical industry, Security printing, Risk management

The "Pharmaceutical Traceability Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pharmaceutical Traceability Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's offering.
  • The Global Pharmaceutical Traceability Market refers to the industry dedicated to ensuring the transparency, authenticity, and security of pharmaceutical products throughout the supply chain.
  • It's clear that the pharmaceutical industry is undergoing significant changes and challenges, which are driving the adoption of traceability solutions.
  • North America is expected to dominate the pharmaceutical traceability market due to its strong pharmaceutical industry, stringent regulations, technological infrastructure, and focus on patient safety.

Global Pharmaceutical Traceability Market Research Report 2023: Blockchain Integration, IoT Sensors, Regulatory Evolution, and Mobile Applications Gaining Momentum - Forecast to 2028

Retrieved on: 
Wednesday, December 13, 2023
Internet of things, Patient safety, EMA, Blockchain, FDA, Mobile app, Humidity, RFID, Counterfeit, Temperature, Counterfeit medications, Public, Transport, Generic drug, Medical device, Pharmaceutical industry, Security printing, Risk management

The Global Pharmaceutical Traceability Market refers to the industry dedicated to ensuring the transparency, authenticity, and security of pharmaceutical products throughout the supply chain.

Key Points: 
  • The Global Pharmaceutical Traceability Market refers to the industry dedicated to ensuring the transparency, authenticity, and security of pharmaceutical products throughout the supply chain.
  • It's clear that the pharmaceutical industry is undergoing significant changes and challenges, which are driving the adoption of traceability solutions.
  • North America is expected to dominate the pharmaceutical traceability market due to its strong pharmaceutical industry, stringent regulations, technological infrastructure, and focus on patient safety.
  • The pharmaceutical industry faces increasingly stringent regulatory requirements from agencies like the FDA and EMA, particularly related to traceability.